88) Ramani NS, Aung PP, Gu J, et al. TERT amplification but not activation of canonical Wnt/β-catenin pathway is involved in acral lentiginous melanoma progression to metastasis // Mod Pathol. 2020 May 13. doi: 10.1038/s41379-020-0565-5
89) Liu R, Pugliano-Mauro M, Patton T, Wang L, Siripong N, Ferris LK. Re-evaluating the ABCD criteria using a consecutive series of melanomas. J Am Acad Dermatol. 2020 Oct;83(4):1161-1163. doi: 10.1016/j.jaad.2020.04.076. Epub 2020 Apr 22. PMID: 32334058
90) Bierhoff E. Dysplastischer melanozytärer Nävus [Dysplastic melanocytic nevus]. Pathologe. 2015 Feb;36(1):46-50, 52. German. doi: 10.1007/s00292-014-2061-5
91) Vuong KT, Walker J, Powell HB, Thomas NE, Jonas DE, Adamson AS. Surgical re-excision vs. observation for histologically dysplastic naevi: a systematic review of associated clinical outcomes. Br J Dermatol. 2018 Sep;179(3):590-598. doi: 10.1111/bjd.16557. Epub 2018 Jun 21. PMID: 29570779.
92) Kim CC, Berry EG, Marchetti MA, Swetter SM, Lim G, Grossman D, Curiel-Lewandrowski C, Chu EY, Ming ME, Zhu K, Brahmbhatt M, Balakrishnan V, Davis MJ, Wolner Z, Fleming N, Ferris LK, Nguyen J, Trofymenko O, Liu Y, Chen SC; Pigmented Lesion Subcommittee, Melanoma Prevention Working Group. Risk of Subsequent Cutaneous Melanoma in Moderately Dysplastic Nevi Excisionally Biopsied but With Positive Histologic Margins. JAMA Dermatol. 2018 Dec 1;154(12):1401-1408. doi: 10.1001/jamadermatol.2018.3359
93) Loh J, Kenny P. Meyerson phenomenon. J Cutan Med Surg. 2010 Jan-Feb;14(1):30-2. doi: 10.2310/7750.2009.08065. PMID: 20128988.
94) Tannous Z. S., Mihm M. C., Jr., Sober A. J., Duncan L. M. Congenital melanocytic nevi: clinical and histopathologic features, risk of melanoma, and clinical management // J Am Acad Dermatol. ‒ 2005. ‒ T. 52, № 2. ‒ C. 197-203. 77.
95) Price H. N. Congenital melanocytic nevi: update in genetics and management // Curr Opin Pediatr. ‒ 2016. ‒ T. 28, № 4. ‒ C. 476-82.
96) Дорошенко М. Б., Утяшев И. А., Демидов Л. В., Алиев М. Д. Клинические и биологические особенности гигантских врожденных невусов у детей // Педиатрия. ‒ 2016. ‒ T. 95, № 4. ‒ C. 50-56
97) . Yun S. J., Kwon O. S., Han J. H., Kweon S. S., Lee M. W., Lee D. Y., Kim M. B., Kim Y. C., Yoon T. Y., Chung K. Y., Kim I. H., Kim K. H., Suh K. S., Lee S. J., Seo Y. J., Kim K. H., Park H. J., Roh M. R., Ahn K. J., Yoon T. J., Kim M. H., Li K. S., Park J. S., Shin B. S., Ko J. Y., Ahn H. H., Kim H. J., Park S. D., Jang S. J., Won Y. H. Clinical characteristics and risk of melanoma development from giant congenital melanocytic naevi in Korea: a nationwide retrospective study // Br J Dermatol. ‒ 2012. ‒ T. 166, № 1. ‒ C. 115-23
98) Mir, A., et al. Giant Congenital Melanocytic Nevus Treated With Trametinib // Pediatrics. 2019 March. 143 (3) e20182469. doi: 10.1542/peds.2018-2469
99) Yu Q, Wu M, Sheng L, et al. Therapeutic effects of targeting RAS-ERK signaling in giant congenital melanocytic nevi. Am J Transl Res 2018; 10:1184–1194
100) Masnari O, Neuhaus K, Aegerter T, Reynolds S, Schiestl CM, Landolt MA. Predictors of Health-related Quality of Life and Psychological Adjustment in Children and Adolescents With Congenital Melanocytic Nevi: Analysis of Parent Reports. J Pediatr Psychol. 2019 Jul 1;44(6):714-725. doi: 10.1093/jpepsy/jsz017. PMID: 30916755.
101) Tanner L., Keppner K., Lesmeister D., Lyons K., Rock K., Sparrow J. Cancer Rehabilitation in the Pediatric and Adolescent/Young Adult Population // Semin Oncol Nurs. ‒ 2020. ‒ T. 36, № 1. ‒ C. 150984.
102) Siegel G. W., Biermann J. S., Chugh R., Jacobson J. A., Lucas D., Feng M., Chang A. C., Smith S. R., Wong S. L., Hasen J. The multidisciplinary management of bone and soft tissue sarcoma: an essential organizational framework // J Multidiscip Healthc. ‒ 2015. ‒ T. 8. ‒ C. 109-15.
103) Salerni G, Teran T, Puig S, et al. Meta-analysis of digital dermoscopy follow-up of melanocytic skin lesions: a study on behalf of the International Dermoscopy Society. J Eur Acad Dermatol Venereol. 2013 Jul;27(7):805–814. doi: 10.1111/jdv.12032
104) Puig S, Malvehy J. Monitoring patients with multiple nevi. Dermatol Clin. 2013 Oct;31(4):565-77, viii. doi: 10.1016/j.det.2013.06.004
105) Adler, N.R., et al., Methods of melanoma detection and of skin monitoring for individuals at high risk of melanoma: new Australian clinical practice. Med J Aust, 2019. 210(1): p. 41-47.
106) Tschandl, P., et al., Melanomas vs. nevi in high-risk patients under long-term monitoring with digital dermatoscopy: do melanomas and nevi already differ at baseline? J Eur Acad Dermatol Venereol, 2017. 31(6): p. 972-977.
107) Giavedoni, P., et al., Familial Melanoma Associated with Li-Fraumeni Syndrome and Atypical Mole Syndrome: Total-body Digital Photography, Dermoscopy and Confocal Microscopy. Acta Derm Venereol, 2017. 97(6): p. 720-723.
108) Kittler, H., et al., Identification of clinically featureless incipient melanoma using sequential dermoscopy imaging. Arch Dermatol, 2006. 142(9): p. 1113-9.
109) Rinner, C., et al., Long-term evaluation of the efficacy of digital dermatoscopy monitoring at a tertiary referral center. J Dtsch Dermatol Ges, 2017. 15(5): p. 517-522.
110) Robinson, J.K. and B.J. Nickoloff, Digital epiluminescence microscopy monitoring of high-risk patients. Arch Dermatol, 2004. 140(1): p. 49-56.
111) Moscarella, E., et al., Both short-term and long-term dermoscopy monitoring is useful in detecting melanoma in patients with multiple atypical nevi. J Eur Acad Dermatol Venereol, 2017. 31(2): p. 247-251.